Investors

Insider Transactions

Date Name Title Type Sorted Descending Shares Traded Price Range
Feb 26, 2015 tessier-lavigne marc Director Option Execute 3,000 50.91
Aug 26, 2014 tessier-lavigne marc Director Option Execute 1,387 50.91
Aug 27, 2014 tessier-lavigne marc Director Option Execute 3,000 50.91
May 6, 2013 tessier-lavigne marc Director Option Execute 13,334 50.91 - 57.11
Nov 23, 2012 vagelos p roy Officer Option Execute 312,500 19.43
Sep 18, 2013 vagelos p roy Officer Option Execute 312,500 13.00
Aug 26, 2014 vagelos p roy Officer Option Execute 303,909 11.64
Aug 7, 2014 vagelos p roy Officer Option Execute 270,352 9.49
Feb 27, 2014 vagelos p roy Officer Option Execute 70,879 9.49 - 21.92
May 12, 2016 vagelos p roy Officer Option Execute 230,684 20.32
Dec 8, 2009 vagelos p roy Director Option Execute 187,500 8.77
Aug 31, 2011 vagelos p roy Officer Option Execute 312,500 28.01
Dec 19, 2008 vagelos p roy Director Option Execute 130,000 7.41
Feb 27, 2008 vagelos p roy Director Option Execute 6,666 7.91
Aug 4, 2011 van plew daniel p Officer Option Execute 4,784 20.90
Apr 27, 2012 van plew daniel p Officer Option Execute 35,216 20.90
Jan 18, 2011 van plew daniel p Officer Option Execute 25,000 20.90 - 21.92
Dec 16, 2010 van plew daniel p Officer Option Execute 25,000 20.90
May 17, 2016 van plew daniel p Officer Option Execute 9,460 30.63
Nov 6, 2015 van plew daniel p Officer Option Execute 11,186 30.63
Showing 401-420 of 1039 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)